ROX Medical Raises $40M Financing
September 6, 2016ROX Medical, a privately held clinical-stage medical device company developing technologies for hypertension, announced today that it has secured $40M in Series E financing.
More »
GENOMIC HEALTH AND EPIC SCIENCES ANNOUNCE STRATEGIC COLLABORATION TO DELIVER NOVEL AR-V7 LIQUID BIOPSY TEST
July 7, 2016VALIDATION STUDY LED BY MEMORIAL SLOAN KETTERING CANCER CENTER, PUBLISHED IN JAMA ONCOLOGY, DEMONSTRATED PATIENTS WITH AR-V7 POSITIVE CIRCULATING TUMOR CELLS HAVE SIGNIFICANTLY BETTER OUTCOMES IF TREATED WITH CHEMOTHERAPY VERSUS HORMONAL TREATMENTS
More »
Marinus Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial for Ganaxolone IV
June 22, 2016Ganaxolone IV Program Aimed at Status Epilepticus Target Indication
More »